Which has the lower trailing P/E, MTD or UTHR?

UTHR has the lower trailing P/E: MTD trades at 29.79 and UTHR at 17.84. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MTD or UTHR?

Over the past five years, UTHR grew revenue faster — MTD at a 3.54% CAGR versus UTHR at 14.68%.

Is MTD or UTHR more profitable?

UTHR runs the higher net margin — MTD at 21.91% versus UTHR at 41.56%.

How have MTD and UTHR total returns compared?

Over the past 10 years, MTD delivered 12.66% and UTHR delivered 14.88% annualized total return. Past performance doesn't predict future results.

Mettler-Toledo International Inc. (MTD) vs United Therapeutics Corporation (UTHR)

A side-by-side comparison of Mettler-Toledo International Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 9, 2026. Differences are shown without an overall score or investment verdict.

MTD

Mettler-Toledo International Inc.

$26.08B

$1,290.36HealthcareDelayed quote: Sep 9, 2026, 4:00 PM EDT

UTHR

United Therapeutics Corporation

$21.51B

$506.82HealthcareDelayed quote: Sep 9, 2026, 4:00 PM EDT

Total return — MTD vs UTHR

growth of $100 · dividends reinvested · last 10y

MTD +235.9% (+12.9%/yr)UTHR +306.6% (+15.1%/yr)UTHR compounded faster over this window

MTD UTHR

MTD vs UTHR: by the numbers

•MTD is the larger company ($26.08B vs $21.51B market cap).
•UTHR trades at the lower trailing earnings multiple (17.84 vs 29.79 P/E), one valuation lens rather than an overall verdict.
•UTHR converts more revenue to profit (41.56% vs 21.91% net margin).
•UTHR grew revenue faster over the past five years (14.68% vs 3.54% CAGR).

Metrics side by side

Valuation

Metric	MTD	UTHR
P/E ratio	29.79	17.84
Forward P/E	28.01	19.05
P/S ratio	6.47	7.23
P/B ratio	2084.60	3.56
EV / EBITDA	21.86	14.05
FCF yield	3.23%	4.79%

Profitability

Metric	MTD	UTHR
Gross margin	59.30%	86.14%
Operating margin	28.69%	44.49%
Net margin	21.91%	41.56%
ROE	7062.40%	20.48%
ROIC	38.57%	17.69%

Growth (annualized)

Metric	MTD	UTHR
Revenue CAGR (5Y)	3.54%	14.68%
EPS CAGR (5Y)	10.81%	20.93%
FCF CAGR (5Y)	2.13%	14.31%
Total return CAGR (5Y)	-3.74%	18.79%

Frequently asked

Which has the lower trailing P/E, MTD or UTHR?: UTHR has the lower trailing P/E: MTD trades at 29.79 and UTHR at 17.84. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MTD or UTHR?: Over the past five years, UTHR grew revenue faster — MTD at a 3.54% CAGR versus UTHR at 14.68%.
Is MTD or UTHR more profitable?: UTHR runs the higher net margin — MTD at 21.91% versus UTHR at 41.56%.
How have MTD and UTHR total returns compared?: Over the past 10 years, MTD delivered 12.66% and UTHR delivered 14.88% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MTD analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

Mettler-Toledo International P/E ratio United Therapeutics P/E ratio Mettler-Toledo International ROE United Therapeutics ROE Mettler-Toledo International operating margin United Therapeutics operating margin Mettler-Toledo International revenue growth United Therapeutics revenue growth Mettler-Toledo International free cash flow United Therapeutics free cash flow

Mettler-Toledo International & United Therapeutics appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 9, 2026.